A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT04976322. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
Study identification
- NCT ID
- NCT04976322
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 760 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2021
- Primary completion
- Aug 6, 2030
- Completion
- Aug 6, 2030
- Last update posted
- Sep 3, 2026
2021 – 2030
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sl0046 50140 | Birmingham | Alabama | 35294 | — |
| Sl0046 50058 | Avondale | Arizona | 85392 | — |
| Sl0046 50662 | Glendale | Arizona | 85306 | — |
| Sl0046 50052 | Phoenix | Arizona | 85032 | — |
| Sl0046 50328 | Tucson | Arizona | 85704 | — |
| Sl0046 50383 | Beverly Hills | California | 90210 | — |
| Sl0046 50275 | La Palma | California | 90623-1730 | — |
| Sl0046 50316 | San Leandro | California | 94578 | — |
| Sl0046 50339 | Denver | Colorado | 80230 | — |
| Sl0046 50239 | Brandon | Florida | 33511 | — |
| Sl0046 50362 | Gainesville | Florida | 32610 | — |
| Sl0046 50681 | Miami | Florida | 33172 | — |
| Sl0046 50059 | Ormond Beach | Florida | 32174 | — |
| Sl0046 50324 | Plantation | Florida | 33324 | — |
| Sl0046 50329 | Tampa | Florida | 33606 | — |
| Sl0046 50698 | Tampa | Florida | 33618 | — |
| Sl0046 50368 | Atlanta | Georgia | 30303 | — |
| Sl0046 50240 | Idaho Falls | Idaho | 83404 | — |
| Sl0046 50699 | Chicago | Illinois | 60616 | — |
| Sl0046 50474 | Hopkinsville | Kentucky | 42240-1746 | — |
| Sl0046 50285 | Lake Charles | Louisiana | 70605 | — |
| Sl0046 50660 | New Orleans | Louisiana | 70112 | — |
| Sl0046 50015 | Hagerstown | Maryland | 21740 | — |
| Sl0046 50219 | Detroit | Michigan | 48201 | — |
| Sl0046 50273 | Las Vegas | Nevada | 89128 | — |
| Sl0046 50366 | Canton | New York | 13617 | — |
| Sl0046 50264 | Manhasset | New York | 11030 | — |
| Sl0046 50334 | New York | New York | 10032 | — |
| Sl0046 50238 | Charlotte | North Carolina | 28211 | — |
| Sl0046 50147 | Hershey | Pennsylvania | 17033 | — |
| Sl0046 50001 | Jackson | Tennessee | 38305 | — |
| Sl0046 50418 | Colleyville | Texas | 76034 | — |
| Sl0046 50050 | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04976322, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04976322 live on ClinicalTrials.gov.